Guadecitabine increases response to combined anti-CTLA-4 and anti-PD-1 treatment in mouse melanoma in vivo by controlling T-cells, myeloid derived suppressor and NK cells. - Amaro, Adriana; Reggiani, Francesco; Fenoglio, Daniela; Gangemi, Rosaria; Tosi, Anna; Parodi, Alessia; Banelli, Barbara; Rigo, Valentina; Mastracci, Luca; Grillo, Federica; Cereghetti, Alessandra; Tastanova, Aizhan; et al. (Journal of Experimental & Clinical Cancer Research (17569966), 2023)